BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Hallucinogens Drug Abuse

Download PDF PDF Version

Image Results

Loading...

Recent Publications on Hallucinogens Drug Abuse:

Pubmed Logo
DMT at fifty.
The steps taken for the discovery of the hallucinogenic effects of...
27th June, 2008
Neuropsychopharmacol Hung. 2007 Dec;9(4):201-5.
From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?
Addictive drugs can profoundly affect social behaviour both acutely and in...
20th June, 2008
School of Psychology, University of Sydney, Sydney, Australia. Br J Pharmacol. 2008 May;154(2):358-68.
DOI Direct Link
Trends in population drug use in New Zealand: findings from national household surveying of drug use in 1998, 2001, 2003, and 2006.
AIM: To track trends in drug use in the New Zealand population over the...
18th June, 2008
Centre for Social and Health Outcomes Research and Evaluation, Massey N Z Med J. 2008 May 23;121(1274):61-71.
Developmental effects of 3,4-methylenedioxymethamphetamine: a review.
+/-3,4-Methylenedioxymethamphetamine (MDMA) is a chemical derivative of...
18th June, 2008
Division of Neurology, Cincinnati Children's Research Foundation, 3333 Behav Pharmacol. 2008 Mar;19(2):91-111.
DOI Direct Link
[Bromo-dragon fly--life-threatening drug. Can cause tissue necrosis as demonstrated by the first described case]
AIM: To track trends in drug use in the New Zealand population over the...
6th June, 2008
Anestesi- och intensivvardskliniken, Universitetssjukhuset i Lund. Lakartidningen. 2008 Apr 16-22;105(16):1199-200.

View more research publications.

BioNews Results for Hallucinogens Drug Abuse:

RSS Logo
BioPortfolio Logo
Sunglasses Keep Eyes Healthy
R News:  Jun 28 2008 1:52AM Matching: drug abuse
FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Defic
KOTA Territory News:  Jun 28 2008 3:51AM Matching: drug abuse
Alkermes Initiates Phase 3 Clinical Study of Vivitrol for the Treatment of Opioid Dependence
Pharma Live:  Jun 27 2008 5:03AM Matching: drug abuse
Alkermes Initiates Phase 3 Clinical Study of VIVITROL(R) for the Treatment of Opioid Dependence
DiGiTAL50:  Jun 27 2008 12:24PM Matching: drug abuse
HIV Life Expectancy Approaching Normal
MedPage Today:  Jun 27 2008 8:54PM Matching: drug abuse
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

BioPortfolio Ltd. offers e-mail and postal lists for Hallucinogens Drug Abuse scientists - we have details of around 364 individuals working on Hallucinogens Drug Abuse .


This page has been viewed 67 times
Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Hallucinogens Drug Abuse across BioPortfolio, or bestselling Hallucinogens Drug Abuse books or recently published Hallucinogens Drug Abuse books .
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional